Wortis, H H <br/><br/>
B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Apr 1995 
 - 3348-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.92.8.3348  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--biosynthesis<br/>Antigens, Differentiation, B-Lymphocyte--metabolism<br/>B-Lymphocytes--drug effects<br/>CD40 Antigens<br/>CD5 Antigens<br/>Cells, Cultured<br/>Cyclic AMP--analogs & derivatives<br/>Cyclosporine--pharmacology<br/>Dose-Response Relationship, Drug<br/>Flow Cytometry<br/>Immunoglobulin M--metabolism<br/>Immunologic Capping<br/>Lymphocyte Activation--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred CBA<br/>Receptors, Antigen, B-Cell--metabolism<br/>Receptors, IgE--biosynthesis<br/>Signal Transduction<br/>Spleen--cytology<br/>Tacrolimus--analogs & derivatives<br/>Thionucleotides--pharmacology